 |
|
 |
Prescription Errors and Their Legal Consequences: Best Practices for Prevention
Provided by: Power-Pak C.E.®
This program is designed to investigate possible causes of prescription medication errors from a legal standpoint by providing the most current data available and presenting strategies to improve safety in health care. ... |
 |
Tapentadol IR: A Gain for Pain?
Provided by: The Collaborative Education Institute
Learning Objectives
1. Describe the mechanism of action of tapentadol immediate release (IR).
2. Determine the appropriate dose and dosing schedule for tapentadol IR.
3. Recognize tapentadol IR's contraindications, warnings and precautions.
4. Identify adverse effects that have been associated with tapentadol IR.
5. Discuss potential drug-drug... |
|
Continuing Professional Development (CPD) 101
Provided by: The Collaborative Education Institute
Learning Objectives:
Upon successful completion of this activity, pharmacists should be able to:
1. Define Continuing Professional Development (CPD)
2. Describe the need to improve how pharmacists approach their continuing education and
lifelong learning
3. List and describe the components of CPD
4. Apply knowledge to a personal CPD example
... |
 |
Diabetic Neuropathy
Provided by: Ohio Northern University
Description:
Diabetic neuropathy is a heterogeneous disease state in which prevention and therapy must be individualized. Diabetic neuropathy is a complication that will continue to increase in prevalence in the future. As healthcare practitioners, we have a duty to educate patients how to minimize their risk for developing diabetic neuropathy a... |
 |
Expanding the Treatment Armamentarium for Non-Small-Cell Lung Cancer: Pharmacist Perspectives
Provided by: ASiM
Lung cancer is the leading cause of cancer-related mortality in the United States, accounting for more than 200 000 new cancer cases and more than 150 000 cancer-related deaths each year. Non–small-cell lung cancer (NSCLC) accounts for more than 85% of lung cancer cases, and is usually associated with a poor prognosis. Health-system pharmacists p... |
 |
Building the bridge to partnership: Fostering the community and managed care pharmacy relationship
Provided by: Academy of Managed Care Pharmacy
Description:
Discover how managed care organizations and community pharmacists are working together to help advance medication therapy management services.... |
|
Actionable Insights to the Evolving Management of MS: Important Considerations in Improving Outcomes
Provided by: ASiM
The introduction of treatments designed to change the natural disease course of multiple sclerosis (MS) has focused attention on the economic burden of this disease. Economic evaluations, which analyze the burden of MS on society and the cost effectiveness of new therapies, stress that the economic burden of a disease should be seen in a global per... |
|
The Rheumatoid Arthritis Landscape: An Update for Managed Care and Specialty Pharmacists
Provided by: ASiM
Rheumatoid arthritis (RA) is a disabling autoimmune disease that causes pain, stiffness, swelling, and limitation of motion in multiple joints, as well as inflammation in other organs. An estimated 1.3 million Americans are affected. Traditionally, RA has been treated with synthetic disease-modifying antirheumatic drugs (DMARDs) and nonsteroidal an... |
|
Managing Drug Interactions with Warfarin
Provided by: The Collaborative Education Institute
Learning Objectives:
Upon successful completion of this program, pharmacists should be able to:
1. Identify factors that contribute to the high prevalence of warfarin drug interactions.
2. Describe the typical time course for warfarin drug interactions.
3. Describe mechanisms for warfarin drug interactions.
4. Discuss various types of drugs or... |
 |
Optimizing Outcomes for Patients With Growth Hormone Deficiency and Other Growth Disorders in Managed Care
Provided by: Impact Education, LLC
Target Audience
- Medical Directors and Pharmacy Directors from health plans, HMOs, integrated health systems, employers, quality organizations, and other managed care organizations
- Managed care-affiliated care team members involved with patient evaluation, education, and follow-up for growth/growth disorders including: physicians, pharmacist... |
 |
Therapeutic Update 2012
Provided by: University Learning Systems
Session 1 – Diabetes Update: Evidence Based Approaches to the Management of Type 2 Diabetes
Session 2 – Thursday: New Drug Update - Part I
Session 3 – Friday: New Drug Update - Part II
... |
 |
HIPAA Privacy Training for the Pharmacy Workforce (v4)
Provided by: Ohio Pharmacists Association
Key to learning objectives:
* P = Pharmacist
* T = Technician
At the successful completion of this course, you will be able to:
* Describe the definition of HIPAA and explain the effects on pharmacy workplace. [P]
* Describe what HIPAA is and what it affects. [T]
* Identify HIPAA basics, including Covered Entities and Protected ... |
 |
Diabetes and Insulin
Provided by: Pharmacy Society of Wisconsin
At the conclusion of this activity, the pharmacists
should be able to:
* Describe diabetes and the proper treatment
* Describe the history of insulin
* Discuss why patients use insulin therapy
* Identify considerations in the dispensing of insulin
* Classify various types of insulin products... |
|
Pharmacy Law
Provided by: Pharmacy Society of Wisconsin
Goal: To help pharmacy technicians understand and identify the major legal rules and regulations dealing with the practice of pharmacy.... |
|
Time and Stress Management
Provided by: Pharmacy Society of Wisconsin
At the conclusion of this lesson, successful participants should be able to:
1. Explain how time pressures and other stressors negatively affect their social and
occupational functioning and their physical and mental health.
2. Discuss various techniques to managing ones' time and learn a system for
scheduling one's activities.
3. Recognize sy... |
|
A Role for Pharmacists: Improving Persistence with Stroke Prevention Medications
Provided by: The Collaborative Education Institute
Learning Objectives:
Upon successful completion of this activity, pharmacists and student pharmacists should be able to:
1. Discuss the guidelines for secondary stroke prevention.
2. Describe the generalizability of the study results to patients in your pharmacy practice.
3. Evaluate the impact of the study on the role of the pharmacist for sec... |
|
Preventing Fraud, Waste & Abuse in Pharmacy Practice -Specialized
Provided by: Ohio Pharmacists Association
At the completion of this program, you should be able to:
* Explain the federal regulations related to fraud, waste and abuse
* Describe how Medicaid & Medicare fraud, waste and abuse regulations affect your daily work
* Describe the components of your company's fraud, waste and abuse compliance program
* State your responsibi... |
|
Improving MS Care: Perspectives from a Medical Director, Pharmacy Director, and Specialty Pharmacist
Provided by: ASiM
Multiple sclerosis (MS) is a costly disease in terms of its effects on patients’ quality of life and its financial cost to society. The introduction of treatments that are designed to change the natural disease course has focused attention on the economic burden of MS. Balancing cost-effective treatment with current guidelines and optimal therapy... |
 |
HIV/AIDS: A Primer for Pharmacists
Provided by: U.S. Pharmacist
This accredited activity is targeted to pharmacists and pharmacy technicians. Estimated time to complete this activity is 120 minutes.
GOAL:
To provide an overview of HIV and AIDS, including clinical features, diagnosis, and treatment strategies.
OBJECTIVES:
After completing this activity, the participant should be able to:
1. Explain th... |
|
Is it Possible to Significantly Limit or Halt the Damage from Rheumatoid Arthritis (RA)? — The Benefits of Anti-TNF Therapy in Managed Care
Provided by: Impact Education, LLC
TARGET AUDIENCE
This activity has been designed to meet the educational needs of managed care pharmacists, pharmacy directors, medical directors, quality directors, policy executives, managed care affiliated physicians, employer and government policy administrators, and other managed care administrators.
STATEMENT OF NEED
The advent of the ant... |
|
Atrial Fibrillation and Managed Care: Current Approaches and Future Directions for Long-Term Therapy
Provided by: Academy of Managed Care Pharmacy
Atrial fibrillation (AF), a common age-related arrhythmia, is a major public health problem in the United States.
The first article in this supplement describes trends in the prevalence and incidence of AF in the United States and the etiology of, risk factors for, complications of, and economic burden of AF.
The second article in this supplement... |
|
How Thick is Too Thick for your Arteries? Ezetimibe vs Niacin for Cardiovascular Risk Reduction?
Provided by: Pharmacy Society of Wisconsin
* Compare second-line lipid lowering agents for special patient populations
* Assess carotid artery media thickness as a clinical endpoint
* Evaluate the primary literature of ezetimibe versus niacin as a guide for therapy management of cardiovascular risk reduction... |
|
Navigating the Management of Chronic Pain:
A Pharmacist's Guide
Provided by: Power-Pak C.E.®
Provide the pharmacist with practical information to support the assessment and management of patients with chronic pain.... |
|
Strategies for Lifelong Learning in Pharmacy CPD 101
Provided by: The Collaborative Education Institute
1. Define Continuing Professional Development (CPD)
2. Describe the need to improve how pharmacists approach their continuing education
and lifelong learning
3. List and describe the components of CPD
4. Apply knowledge to a personal CPD example
5. Compare and contrast the traditional CE model with a CPD model... |
|
Endemic Mycoses in Wisconsin: An Update on Treatment and the Role of the Pharmacist
Provided by: Pharmacy Society of Wisconsin
To provide an update on the treatment of mycoses endemic to Wisconsin and review Infectious Diseases Society of America.... |
|
Immunization Update -2010
Provided by: The Collaborative Education Institute
Learning Objectives:
Upon successful completion of this activity, pharmacists should be able to:
1. Use updated guidelines for seasonal influenza immunizations to recommend vaccination.
2. Describe the universal influenza vaccine recommendation.
3. Explain the advantages and limitations of the high dose influenza vaccine for the elderly.
4. Di... |
|
Managing Joint Pain and Associated Conditions
Provided by: Power-Pak C.E.®
To provide pharmacists with an update on the newer approaches to the management of osteoarthritis and provide strategies for educating, counseling, and monitoring patients about the relief of joint pain.... |
|
Hyperthyroidism: Exploring Treatment Strategies
Provided by: U.S. Pharmacist
After completing this activity, the participant should be able to:
1.Explain the biosynthesis, transport, and control of thyroid hormones.*
2.Discuss the etiology and diagnosis of hyperthyroidism.*
3.Review treatment options for hyperthyroidism.*
4.Develop an individualized pharmacotherapy and monitoring plan for the management of hyperthyr... |
 |
Health Insurance Advanced Studies, Part A online course.
Provided by: America's Health Insurance Plans
You understand the health insurance industry and continuously work to stay ahead of the trends and changes. This online course advances your knowledge on a full range of topics within health insurance including health insurance plan structures and alternatives, prescription drugs, and pharmacy benefit news, Medicare and Part D, Medicaid, tax treatm... |
|
Substitution of Generic Drugs for Brand Name Drugs
Provided by: Pharmacy Society of Wisconsin
At the conclusion of this lesson, successful participants should be able to:
1. Explain the requirements for approval of a generic drug
product.
2. Explain how therapeutic equivalence of generic drugs is
established and how the FDA rating system is used.
3. Provide patient education tips for common questions regarding generic drugs.... |
|
|
Virtual Exhibits / Booths
Join Email List
Visit Our Website
View Literature
